540 results on '"Cacabelos, Ramón"'
Search Results
2. Contributors
3. Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development
4. Targeting epigenetics as future treatments of trauma- and stress-or-related disorders. Epidrugs and epinutraceuticals
5. Genomics of Brain Disorders 4.0
6. Pharmacogenomics: A gateway to personalized medicine
7. Farmacogenómica: Una puerta de acceso a la medicina personalizada
8. Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease
9. Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders
10. Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders
11. Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration
12. Pharmacogenomics of Antidepressant Drugs
13. Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders
14. Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics
15. Pharmacoepigenetics: A Long Way Ahead
16. The Epigenetic Machinery in the Life Cycle and Pharmacoepigenetics
17. Contributors
18. Pharmacoepigenetics of Vertigo and Related Vestibular Syndromes
19. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis
20. Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders
21. Pharmacogenetics of Neurodegenerative Disorders
22. Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and Nox-derived ROS in rat hippocampal slices
23. Oxidative Stress-Induced Mitochondrial Damage as a Hallmark for Drug Development in the Context of the Neurodegeneration, Cardiovascular, and Cerebrovascular Diseases
24. Implication of Oxidative Stress-Induced Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegeneration and Cancer
25. The Three-Vessel Occlusion as a Model of Vascular Dementia – Oxidative Stress and Mitochondrial Failure as an Indicator of Brain Hypoperfusion
26. Potential Preventive Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion
27. Atherosclerotic Lesions and Mitochondrial DNA Deletions as a Primary Hallmark of the Brain Microcirculation – Implication in the Pathogenesis of Alzheimer’s Disease
28. List of Contributors
29. Basic and Clinical Studies With Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders
30. Epigenetic Drug Discovery for Alzheimer’s Disease
31. Epigenetics of Brain Aging
32. List of Contributors
33. Gene Expression Profiling as a Novel Diagnostic Tool for Neurodegenerative Disorders
34. Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
35. DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders
36. Cardiovascular and lipid-lowering effects of a marine lipoprotein extract in a high-fat diet-induced obesity mouse model
37. Pharmacogenetics of anxiety and depression in Alzheimer's disease
38. ACTN3 genotype influences exercise-induced muscle damage during a marathon competition
39. Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
40. Epigenomics of Alzheimer's Disease
41. Pharmacogenomic Biomarkers in Neuropsychiatry: The Path to Personalized Medicine in Mental Disorders
42. Pleiotropic Effects of Apolipoprotein E in Dementia: Influence on Functional Genomics and Pharmacogenetics
43. New Paradigms in Pharmaceutical Development
44. Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease
45. The Histamine-Cytokine Network in Alzheimer Disease: Etiopathogenic and Pharmacogenomic Implications
46. Proteomic and Global DNA Methylation Modulation in Lipid Metabolism Disorders with a Marine-Derived Bioproduct.
47. Preface
48. Preface
49. Pharmacogenetics for Improving Efficacy and Safety in Drug Development and for Reducing Costs in Alzheimer’s Disease
50. Farmacogenómica: Una puerta de acceso a la medicina personalizada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.